Stay updated on SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial page.

Latest updates to the SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial page
- Check7 days agoChange DetectedA site-wide banner announces NIH updates about using “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition.SummaryDifference1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with a standard error screen and site chrome.SummaryDifference20%

- Check63 days agoChange DetectedThe revision label on the page updated from v3.6.5 to v3.6.6, reflecting a small update to the page metadata. This does not indicate changes to the study data or trial details.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page, indicating a minor update to the documentation or metadata. No substantive study content changes are indicated by the provided data.SummaryDifference0.1%

Stay in the know with updates to SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT and Virus Therapy Before Pembrolizumab in Cancer Clinical Trial page.